Alliance Pharma PLC Notification of Major Interest in Shares (9166X)
September 02 2015 - 1:01PM
UK Regulatory
TIDMAPH
RNS Number : 9166X
Alliance Pharma PLC
02 September 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
---------------------------------------------------------------------------------------------
1. Identity of the issuer or ALLIANCE PHARMA PLC
the underlying issuer
of existing shares to which
voting rights are
attached:
------------------------------------------------------------- ------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
----------------------------------------------------------------- --------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
----------------------------------------------------------------- --------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
----------------------------------------------------------------- --------------------------
An event changing the breakdown of voting rights
----------------------------------------------------------------- --------------------------
Other (please
specify):
------------------------------------------------------------ --- --------------------------
3. Full name of person(s) NIGEL WRAY
subject to the
notification obligation:
------------------------------------------------------------- ------------------------------
4. Full name of shareholder(s) PERSHING NOMINEES LIMITED
(if different from 3.): ROY NOMINEES LIMITED
------------------------------------------------------------- ------------------------------
5. Date of the transaction 28(th) August 2015
and date on
which the threshold is
crossed or
reached:
------------------------------------------------------------- ------------------------------
6. Date on which issuer 1(st) September 2015
notified:
------------------------------------------------------------- ------------------------------
7. Threshold(s) that is/are
crossed or
reached: 14%
------------------------------------------------------------- ------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ---------------------------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights
Shares Voting shares rights
Rights
------------- --------------- --------------- -------------- -------------------------- -------------------------
Direct Direct Indirect Direct Indirect
------------- ----------- ----------- -------------- ------------- ----------- ------------ -----------
Ordinary
shares
GB0031030819 40,176,510 40,176,510 15,511,922 15,511,922 22,164,588 5.86% 8.38%
--------------- --------------- -------------- ------------- ----------- ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument Period may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------- ---------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights
instrument period refers to
--------------- ------------- ------------- ---------------- ---------------------------- -----------------------
Nominal Delta
--------------- ------------- ------------- ---------------- ---------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
37,676,510 14.24%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
---------------------------------------------------------------------------------------
Nigel William Wray has a beneficial interest in shares
in Alliance Pharma Plc held by the following nominees
Pershing Nominees Limited 15,511,922
The family of Nigel Wray maintains a beneficial interest
in the shares held by Roy Nominees Limited - 22,164,588
Proxy Voting:
---------------------------------------------------------------------------------------
10. Name of the proxy holder: N/A
------------------------------------------------------- ------------------------------
11. Number of voting rights proxy N/A
holder will cease
to hold:
------------------------------------------------------- ------------------------------
12. Date on which proxy holder will N/A
cease to hold
voting rights:
------------------------------------------------------- ------------------------------
13. Additional information: Figures are based on a total
number of voting rights of
264,080,873
------------------------------------------------------- ------------------------------
14. Contact name: Nigel Wray
------------------------------------------------------- ------------------------------
15. Contact telephone number: 020 7647 7647
------------------------------------------------------- ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAXNAEEESEFF
(END) Dow Jones Newswires
September 02, 2015 13:01 ET (17:01 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024
